Increased gene expression levels of cytotoxic T cells (PRF1 and GZMB) and Th1 cells (IFN-γ and TBX21) are linked to better patient outcomes, according to studies on the gene-expression profiling of CRC tissues. This evidence concerns the gene IFNG and colorectal carcinoma.